Wyświetlanie pozycji 1-2 z 2

    • European multi-center study to establish MIC and zone diameter epidemiological cut- off (ECOFF) values for Bacillus anthracis 

      Dematheis, Flavia; Manzulli, Viviana; Grass, Gregor; Matuschek, Erika; Jacob, Daniela; Melzer, Falk; Elschner, Mandy; Kedrak-Jablonska, Agnieszka; Budniak, Sylwia; Mori, Marcella; Fancello, Tiziano; Grunow, Roland; Kahlmeter, Gunnar; Galante, Domenico; Zange, Sabine (ELSEVIER, 2024)
      ObjectivesBacillus anthracis clinical breakpoints, representing a systematic approach to guide clinicians in selecting the most appropriate antimicrobial treatments, are not part of the guidance from the European Committee ...
    • Lysins as a powerful alternative to combat Bacillus anthracis 

      Nakonieczna, Aleksandra; Abramowicz, Karolina; Kwiatek, Magdalena; Kowalczyk, Ewelina (Springer, 2024)
      This review gathers all, to the best of our current knowledge, known lysins, mainly bacteriophage-derived, that have demonstrated activity against Bacillus anthracis strains. B. anthracis is a spore-forming, toxin-producing ...